PatientPop is the provider of an all-in-one practice growth solution designed to enhance and automate each touchpoint in the patient journey — from first impression online to digital booking to post-visit follow-up — to makes it easy for healthcare providers to attract more patients, manage online reputation, modernize the patient experience, and automate the front office.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
08/25/2020 | Series C-1 | $3.39MM | $xx.xx | $42.59B | Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital | |
Price per Share
$xx.xx
Shares Outstanding
341,859
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
|
||||||
08/25/2020 | Series C-3 | $4.5MM | $xx.xx | $42.59B | Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital | |
Price per Share
$xx.xx
Shares Outstanding
453,400
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
|
||||||
08/25/2020 | Series C-2 | $5.61MM | $xx.xx | $42.59B | Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital | |
Price per Share
$xx.xx
Shares Outstanding
564,942
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
|
||||||
08/25/2020 | Series C | $42.65MM | $xx.xx | $42.59B | Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital | |
Price per Share
$xx.xx
Shares Outstanding
4,297,717
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
|
||||||
10/22/2018 | Series B-2 | $5MM | $xx.xx | $38.58B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
548,846
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/22/2018 | Series A-5 | $10MM | $xx.xx | $38.58B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,321,003
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/22/2018 | Series B-1 | $15MM | $xx.xx | $38.58B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,646,542
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/22/2018 | Series A-4 | $15MM | $xx.xx | $38.58B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,920,390
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
12/29/2016 | Series A-3 | $4.5MM | $xx.xx | $14.83B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,265,502
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
05/17/2016 | Series A-2 | $7.57MM | $xx.xx | $12.12B | Athenahealth, Silicon Valley Bank, Toba Capital | |
Price per Share
$xx.xx
Shares Outstanding
2,599,161
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athenahealth, Silicon Valley Bank, Toba Capital
|
||||||
11/04/2015 | Series A | $10.03MM | $xx.xx | $9.17B | Toba Capital | |
Price per Share
$xx.xx
Shares Outstanding
4,520,473
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Toba Capital
|
||||||
05/13/2015 | Series Seed | $504,997.00 | $xx.xx | $2.97B | -- | |
Price per Share
$xx.xx
Shares Outstanding
841,661
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
--
|
||||||
05/13/2015 | Series Seed-2 | $2.05MM | $xx.xx | $2.97B | Athenahealth | |
Price per Share
$xx.xx
Shares Outstanding
2,828,211
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athenahealth
|